CHRISTINA YERDON: Open Payments
NPI 1336133859 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,754 in 79 payments from 23 companies in 2025. Trend: 2023 $1,665 · 2024 $2,267 · 2025 $1,754
Food & beverage: $1,692Education: $62
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $231 |
| Otsuka America Pharmaceutical, Inc. | 9 | $220 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $208 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $157 |
| Amgen Inc. | 9 | $149 |
| Lilly USA, LLC | 5 | $119 |
| Calliditas Therapeutics US Inc. | 3 | $86 |
| Alexion Pharmaceuticals, Inc. | 4 | $84 |
| OPKO Pharmaceuticals, LLC | 3 | $62 |
| Vifor Pharma, Inc. | 2 | $61 |
Products named: JARDIANCE, JYNARQUE, Kerendia, FARXIGA, KRYSTEXXA, TARPEYO, ULTOMIRIS, RAYALDEE.
Industry payments across NY — which companies pay providers there.
